• Text Size :
    • -
    • +

The 52nd APAN Meeting -APSC Cloud Webinar of Cardiovascular Diseases

Program
Mailing List
Connection Information
Files
Report
ver 2.85

The 52nd APAN Meeting -APSC Cloud Webinar of Cardiovascular Diseasesreload

Local Time at Main Venue 2021.08.04(Wed) 16:30 - 105min, Taipei, TW (UTC+08:00)
Organizer Jiunn-Lee Lin
Topic Assessment & Management of Valvular Heart Diseases (II) : Aortic Valve Disease
Contents Cardiology
Style Conference
Connection Method Zoom, Streaming
Server At https://us02web.zoom.us/j/9996789876
Streaming Address https://www.youtube.com/channel/UCl6LnwGSOSoSFAHuIKWZIXQ
Brief Description "Valvular heart disease have been become a new target of innovation in medical device technology, particularly for minimally invasive or even noninvasive therapy. Transcatheter aortic valve replacement is the most well-known example.
In the Aortic Valve Disease session (II) of APSC Cloud Forum of Valvular Heart Diseases, we’d review the updated severity classification of aortic valve stenosis and aortic regurgitation by cardiac imaging, followed by current medical interventional versus surgical management of aortic valve stenosis in congenital (bicuspid) and degenerative (tricuspid) mechanism, aortic valve stenosis in HFrEF especially when low-flow and low gradient, as well as timing of surgery for severe aortic regurgitation. From congenital to degenerative, from normal to failing heart, aortic valve stenosis and aortic regurgitation management are presenting a new world of biotechnology-aiding medicine."

Key Members

ChairJiunn-Lee LinNational Taiwan UniversityTW
Co-Chair 1---
Co-Chair 2---
Chief Engineer 1Ti-Chuang ChiangNational Taiwan UniversityTW
Chief Engineer 2---
Chief Engineer 3---
Chief Engineer 4---

Connecting Institutions  

Red is to be decided
City, Country Institution Moderator Local Engineer
1(Main).Taipei, TWNational Taiwan UniversityHsi-Yu YuTi-Chuang Chiang
2.Taipei, TWTaiwan Heart Foundation--
3.Singapore, SGNational Heart Centre SingaporeEwe See Hooi-
4.Abu Dhabi, AECleveland Clinic Abu DhabiMahmoud Traina-
5.Toyohashi, JPToyohashi Heart CenterMasanori Yamamoto-
6.Bandar Seri Begawan, BNRIPAS hospitalLau Bee-Ngo-

Schedule

Main venue     Localtime
1.Taipei, TW
(UTC+08:00)
ContentsPresenterUTC+08:00
(Institution No. 2, 3, 6)
UTC+04:00
(Institution No. 4)
UTC+09:00
(Institution No. 5)
2021.08.04
15:30 - 16:30
Connection starts for Final Testing2021.08.04
15:30 - 16:30
2021.08.04
11:30 - 12:30
2021.08.04
16:30 - 17:30
16:30 - 16:33OpenHsi-Yu Yu(National Taiwan University)16:30 - 16:3312:30 - 12:3317:30 - 17:33
16:33 - 16:53Assessment of severity of aortic valve stenosis and aortic regurgitation by cardiac imaging: rheumatic vs. nonrheumaticEwe See Hooi(National Heart Centre Singapore)16:33 - 16:5312:33 - 12:5317:33 - 17:53
16:53 - 16:58Q & AChair 1, 2 & all16:53 - 16:5812:53 - 12:5817:53 - 17:58
16:58 - 17:18Assessment and interventional management of severe tricuspid vs bicuspid aortic valve stenosis: TAVR, SAVR, or Bentall procedure?Mahmoud Traina(Cleveland Clinic Abu Dhabi)16:58 - 17:1812:58 - 13:1817:58 - 18:18
17:18 - 17:23Q & AChair 1, 2 & all17:18 - 17:2313:18 - 13:2318:18 - 18:23
17:23 - 17:43Decision-making in best management of aortic valve stenosis in heart failure with reduced EF: GDMT, TAVR or SAVR?Masanori Yamamoto(Toyohashi Heart Center)17:23 - 17:4313:23 - 13:4318:23 - 18:43
17:43 - 17:48Q & AChair 1, 2 & all17:43 - 17:4813:43 - 13:4818:43 - 18:48
17:48 - 18:08Timing of surgical intervention for severe aortic regurgitation with rheumatic or nonrheumatic mechanism: any point of no return ?Lau Bee-Ngo(RIPAS hospital)17:48 - 18:0813:48 - 14:0818:48 - 19:08
18:08 - 18:13Q & AChair 1, 2 & all18:08 - 18:1314:08 - 14:1319:08 - 19:13
18:13 - 18:15CloseEwe See Hooi(National Heart Centre Singapore)18:13 - 18:1514:13 - 14:1519:13 - 19:15

Precautions

  • The conference will be recorded by the photos and movies.
  • Pictures taken at the conference will be published in TEMDEC home page, annual report and conference presentations.
  • Do not present the personal information of patients any in oral and presentation materials without obtaining the patient's consent.
  • The conference will be delivered simultaneously by streaming.

* For more information, please refer to the TEMDEC policy.